E84 E56
Conditions
Interventions
Group 1: topical liposomes - vitamin A (780 IU as retinyl palmitate/day), vitamin D (1500 IU as cholecalciferol/day), vitamin E (1,38 IU as alpha-tocopherol/day), vitamin K (66 mcg of menaquinone-7/da
Sponsors
Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: healthy adults
Exclusion criteria
Exclusion criteria: pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean (or median) change from the baseline in vitamin status in the serum: vitamin A (all-trans-retinol), vitamin D (25-hydroxyvitamin D), vitamin E (alpha-tocopherol), vitamin K (% of uncarboxylated osteocalcin) - after 3 weeks (last 3 days of intervention) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Vitamin status in the serum: vitamin A (all-trans-retinol), vitamin D (25-hydroxyvitamin D), vitamin E (alpha-tocopherol), vitamin K (% of uncarboxylated osteocalcin) - after 3 weeks (last 3 days of intervention) 2. The mean (or median) change from the baseline in the prevalence of vitamin A, D, E, and K deficiency - after 3 weeks (last 3 days of intervention) 3. Planned (depends on feasibility): Concentrations and the mean (or median) change from the baseline of concentrations of vitamin K forms/homologues - after 3 weeks (last 3 days of intervention) | — |
Countries
Poland
Contacts
Public ContactJaroslaw Walkowiak
Department of Pediatric Gastroenterology and Metabolic DiseasesPoznan University of Medical Sciences
Outcome results
None listed